Therapeutic potential of APP antisense oligonucleotides for Alzheimer’s disease and down syndrome-related Alzheimer’s disease
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Therapeutic potential of APP antisense oligonucleotides for Alzheimer’s disease and down syndrome-related Alzheimer’s disease ; volume:19 ; number:1 ; day:29 ; month:7 ; year:2024 ; pages:1-3 ; date:12.2024
Molecular neurodegeneration ; 19, Heft 1 (29.7.2024), 1-3, 12.2024
- Urheber
-
Thirumalai, Srishruthi
Patani, Rickie
Hung, Christy
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s13024-024-00745-5
- URN
-
urn:nbn:de:101:1-2410132120004.381489694458
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:28 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Thirumalai, Srishruthi
- Patani, Rickie
- Hung, Christy
- SpringerLink (Online service)
Ähnliche Objekte (12)
Alzheimer’s Disease
Alzheimer's disease
Endocytosis and Alzheimer’s disease
Biomarkers in Alzheimer’s disease
Genetics of Alzheimer’s disease
Treatments in Alzheimer’s disease
Alzheimer’s disease and immunotherapy
Psychosis in Alzheimer’s Disease
Therapeutic correction of ApoER2 splicing in Alzheimer's disease mice using antisense oligonucleotides
Disease-modifying treatments in Alzheimer’s disease
Alzheimer’s disease as an inflammatory disease
Intranasal Insulin for Alzheimer’s Disease
Alzheimer’s Disease
Alzheimer's disease
Endocytosis and Alzheimer’s disease
Biomarkers in Alzheimer’s disease
Genetics of Alzheimer’s disease
Treatments in Alzheimer’s disease
Alzheimer’s disease and immunotherapy
Psychosis in Alzheimer’s Disease
Therapeutic correction of ApoER2 splicing in Alzheimer's disease mice using antisense oligonucleotides
Disease-modifying treatments in Alzheimer’s disease
Alzheimer’s disease as an inflammatory disease
Intranasal Insulin for Alzheimer’s Disease
Alzheimer’s Disease
Alzheimer's disease
Endocytosis and Alzheimer’s disease
Biomarkers in Alzheimer’s disease
Genetics of Alzheimer’s disease
Treatments in Alzheimer’s disease
Alzheimer’s disease and immunotherapy
Psychosis in Alzheimer’s Disease
Therapeutic correction of ApoER2 splicing in Alzheimer's disease mice using antisense oligonucleotides
Disease-modifying treatments in Alzheimer’s disease
Alzheimer’s disease as an inflammatory disease